Balestrero Federica Carolina, Gioiello Laura, Goutsiou Georgia, Sangaletti Sabina, Di Martino Rita Maria Concetta, Condorelli Fabrizio, Grolla Ambra A, Pirali Tracey
Department of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Largo Donegani 2, Novara 28100, Italy.
Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan 20133, Italy.
ACS Omega. 2025 Jan 30;10(5):4745-4753. doi: 10.1021/acsomega.4c09726. eCollection 2025 Feb 11.
Among the various strategies being developed in the field of protein degraders, HyTags remain relatively underexplored, despite their advantages over PROTACs. Their synthesis typically involves multistep procedures, including the use of coupling reagents and protection/deprotection steps. To develop a more sustainable and streamlined approach, we designed a versatile multicomponent platform that generates HyTags with diverse linkers and hydrophobic moieties in high yields. Using (+)-JQ1 as the POI ligand, we synthesized a series of BRD4-targeting HyTags and discovered that compound induces degradation of BRD4 the autophagy-lysosome pathway through ER stress. This finding further supports the valuable application of this synthetic methodology in the search for effective degraders.
在蛋白质降解剂领域正在开发的各种策略中,HyTags尽管比PROTACs具有优势,但仍相对未得到充分探索。它们的合成通常涉及多步程序,包括使用偶联试剂以及保护/脱保护步骤。为了开发一种更可持续和简化的方法,我们设计了一个通用的多组分平台,该平台能以高产率生成具有不同连接子和疏水部分的HyTags。使用(+)-JQ1作为感兴趣蛋白(POI)配体,我们合成了一系列靶向BRD4的HyTags,并发现化合物 通过内质网应激诱导BRD4在自噬-溶酶体途径中的降解。这一发现进一步支持了这种合成方法在寻找有效降解剂方面的宝贵应用。